Despite acknowledging that breast implants can increase cancer and autoimmune disease risks, the Food and Drug Administration isn’t planning to ban their sales yet. Instead, it issues guidelines to improve patient and healthcare provider information.
Public Health May 4, 2019
CAR-T therapy is known to help patients with blood cancers immensely. Now, researchers show great promise in using the same methods in treating other types of cancer as well.
Medicine April 1, 2019
CAR T-cell therapy had some multiple myeloma patients see significant reduction in their cancer and even enter full remission. How does this gene-based therapy work and what are its side effects?
Medicine June 6, 2017
The FDA announcement on a link between breast implants and ACLC, a rare type of blood cancer, may raise concerns over the safety of breast enhancement procedures. Here are other cosmetic surgeries that come with health risks.
Public Health March 23, 2017
Because of strides in medical treatment, leukemia is no longer the deadliest cancer among U.S. children. What makes treatment of brain cancer difficult?
Public Health September 16, 2016
Swiss drugmaker Roche has announced that the phase III clinical trial for its blood cancer drug did not meet its endpoint. The drug is designed to treat an aggressive form of blood cancer known as diffuse large B-cell lymphoma.
Medicine July 18, 2016
An experimental drug is giving hope to patients suffering from Hodgkin's Lymphoma, an aggressive type of blood cancer. In a successful phase 1 trial, the drug nivolumab delivered 'considerable' reductions in the tumors of about 66.3 percent of the patients.
Medicine June 13, 2016
The FDA approved on May 18 two new immunotherapy drugs, including atezolizumab for advanced bladder cancer. These medications are designed to boost the immune system's own ability to find and kill cancer cells.
Medicine May 19, 2016
European regulators on April 1 issued a conditional approval recommendation for the use of Johnson & Johnson's Darzalex in patients with blood cancer. The committee is awaiting more data from two ongoing studies.
Life April 3, 2016
Farydak made history by being the first histone deacetylase inhibitor with epigenetic activity to be approved in the European Union, offering another treatment option for those with multiple myeloma.
Life September 5, 2015
Somatic mutations in the blood indicate a person's increased likelihood of developing a form of blood cancer within five years. In one study, people who have the mutation were 13 times more likely to develop myelodysplastic syndrome, leukemia or lymphoma compared with those who do not have mutated blood cells.
Life November 28, 2014
Gazyva, a new leukemia drug kills about 90 percent of cancer cells in just the first dose. The drug comes with severe side effects and its treatment involves a hefty $42,000 bill.
Life October 28, 2014
In the Aspire trial involving nearly 800 patients with multiple myeloma, those who took Amgen's Kyprolis coupled with standard treatment were found to live longer before their condition worsened.
Life August 5, 2014
Tom Brokaw of NBC had been diagnosed with a form of blood cancer in last August but his battle with the big C was officially announced only on Tuesday.
Society February 13, 2014